Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to β-cell apoptosis

Pancreas

Volumn 18, Issue 3, 1999, Pages 259-265

  Bar On, Hanoch ^a,b   Ben Sasson, Rivka ^a   Ziv, Ehud ^a   Arar, Nazik ^a   Shafrir, Eleazar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Diabetes reversibility; High energy diet; Insulin resistance Insulin immunohistochemistry; Psammomys obesus; cell apoptosis

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALORIC INTAKE; GERBIL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0033053079     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199904000-00007     Document Type: Article

References (31)

1. Hackel DB, Frohman LA, Mikat E, Lebovitz HE, Schmidt-Nielsen K, Kinney TD. Review of the current studies on effect of diet on the glucose tolerance of the sand rat (Psammomys obesus). Ann N Y Acad Sci 1965;131:459-63.
2. Like AA, Miki E. Diabetic syndrome in sand rats IV: morphologic changes in islet tissue. Diabetologia 1967;3:143-66.
3. Marquie G, Duhault J, Jacotot B. Diabetes mellitus in sand rats (Psammomys obesus): metabolic pattern during development of the diabetic syndrome. Diabetes 1984;33:438-43.
4. Kalderon B, Gutman A, Levy E, Shafrir E, Adler JH. Characterization of stages in the development of the obesity-diabetes syndrome in sand rat (Psammomys obesus). Diabetes 1985;35:717-24.
5. Barnett M, Collier GR, Collier FM, Zimmet P, O'Dea K. A cross-sectional and short term longitudinal characterisation of type 2 diabetes mellitus in Israeli sand rat (Psammomys obesus). Diabetologia 1994;37:671-6.
6. Ziv E, Shafrir E. Psammomys obesus: nutritionally induced NIDDM-like syndrome on a "thrifty gene" background. In: Shafrir E, ed. Lessons from animal diabetes. Vol 5. London: Smith-Gordon, 1995:285-300.
7. Gadot M, Leibowitz G, Shafrir E, Cerasi E, Gross DJ, Kaiser N. Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus. Endocrinology 1994;135:610-6.
8. Kanety H, Moshe S, Shafrir E, Lunenfeld B, Karasik A. Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91: 1853-7.
9. Shafrir E, Gutman A. Psammomys obesus of the Jerusalem colony: a model for nutritionally induced, non-insulin-dependent diabetes. J Basic Clin Physiol Pharmacol 1993;4:83-99.
10. Leckstrom A, Ziv E, Shafrir E, Westermark P. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects on nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment. Pancreas 1997;15:358-66.
11. Kalman R, Adler JH, Ziv E, Lazarovici G, Bar-On H, Ziv E. The efficiency of the sand rat metabolism is responsible for the development of obesity and diabetes. J Basic Clin Physiol Pharmacol 1993;4:57-68.
12. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997;46:750-7.
13. Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem Mol Biol Int 1996;39:1229-36.
14. Jimi A, Kojiro M, Miyasaka K, Kono A, Funakoshi A. Apoptosis in the pancreas of genetically diabetic rats with a disrupted cholecystokinin (CCK-A) receptor gene. Pancreas 1997;14:109-12.
15. Krausz Y, Bar-On H, Shafrir E. Origin and pattern of glucocorticoid-induced hyperlipidemia in rats: dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity. Biochim Biophys Acta 1981;63:69-82.
16. Ziv E, Kalman R, Hershkop K, Barash V, Shafrir E. Bar-On H. Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state. Diabetologia 1996;39: 1269-75.
17. Bendayan M, Malide D, Ziv E, et al. Immunocytochemical investigation of insulin secretion by pancreatic β-cells in control and diabetic Psammomys obesus. J Histochem Cytochem 1995;43:771-84.
18. Ben-Sasson SA, Sherman Y, Gavrieli Y. Identification of dying cells - in situ staining. In: Schwartz LM, Osborne BA, eds. Methods in cell biology. Orlando: Academic Press, 1995:29-39.
19. Egensperger R, Maslim J, Bisti S, Hollander H, Stone J. Fate of DNA from retinal cells dying during development: uptake by microglia and macroglia (Muller cells). Dev Brain Res 1966;97:1-8.
20. Hanson RW, Patel YM. Phosphoenolpyruvate carboxykinase (GTP): the gene and the enzyme. Adv Enzymol Relat Areas Mol Biol 1994;69:203-81.
21. Shafrir E. Nonrecognition of insulin as gluconeogenesis suppressant: a manifestation of selective hepatic insulin resistance in several animal species with type II diabetes: sand rats, spiny mice and db/db mice. In: Shafrir E, ed. Lessons from animal diabetes. Vol 2. London: Smith Gordon, 1988:304-15.
22. Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989;38:550-7.
23. Perriello G, Pampanelli S, Del Sindaco P, et al. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 1997;46:1010-6.
24. Ziv, E, Kalman R, Bar-On H, Shafrir E. Potentiation of insulin action by vanadyl treatment of diabetic Psammomys obesus. Exp Clin Endocr Diabetes 1996;104:164-5.
25. Ziv E, Nachliel I, Bar-On H, Shafrir E. Nutritionally induced insulin resistance in Psammomys obesus: its consequences and its possible prevention. Exp Clin Endocrinol Diabetes 1997;105: 12-3.
26. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
27. Omori S, Morioka T, Wakasugi M, et al. Quantification of apoptotic cells using isolated glomeruli. Nephron 1997;77:474-8.
28. Kerr J, Winterford C, Harmon B. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994;73(80):2013-26.
29. Kaneto H, Fujii J, Myint T, et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 1996; 320:855-63.
30. Donath MY, Gross DJ, Ariav Y, Ayalon L, Cerasi E, Kaiser N. Modulation of islet cell turnover in the diabetes-prone Psammomys obesus by chronic glucose exposure. Acta Diabetol 1998:35(suppl 1):S6.
31. Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998;47:358-64.